Caixin
Apr 21, 2022 08:00 AM

Beihai Gofar Chuanshan Biological Co.,Ltd.’s Net Profit Rose 114.5% in First Quarter of 2022

Beihai Gofar Chuanshan Biological Co.,Ltd. (北海国发川山生物股份有限公司) (600538.SH) reported a net profit of 8.1 million yuan in the first quarter of 2022, up 114.5% year-on-year.

Meanwhile, the company posted 120.8 million yuan in revenue, up 28.5% year-on-year.

At the end of the reporting period, it had 1.1 billion yuan in total assets and 154 million yuan in total liabilities, with a liability-to-asset ratio of 14.2%.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
China Business Uncovered Podcast: Brazil’s ‘Very Chinese Moment’
00:00
00:00/00:00